Funding @ 2013-08-25 08:15:29 UTC 5e9586512842b6b1560475062d382022802d84fadd95b5e7dea1788cbf0bd8f6:0
Spending @ 2013-08-25 11:25:01 UTC 1f2965ef4de220f01b11595a631558e9c34a86762366c0f9b0f49701963a146c:4
|
Funding @ 2013-08-19 14:57:32 UTC 598cab32aa9b7673d20ba077815868d5149c6a7187c5a76a1abd6f697243147b:1
Spending @ 2013-08-21 04:32:13 UTC 7646441e5e70dcfd70d6b1ff6aebb9242b25db0f6a873cff8e136afe843ea642:23
|
Funding @ 2013-08-10 08:22:01 UTC 6b59bf5d7431cd4ec8dec91b95a007ab0ed7ed0f7ea343e5fe9fff30030adb9c:1
Spending @ 2013-08-10 13:45:01 UTC bbdf06aec94fdcb00e66381bca26b792b3ce97bdb9de940f3885ff87a5ba2d30:7
|
Funding @ 2013-08-09 08:39:26 UTC 8b107112e61d2cab28385f49a394371bd6762b1b82e2f73df89980bb2521aca1:2
Spending @ 2013-08-09 10:07:39 UTC 52a3f72a8e7d804d7f254477dd0797f2d85beb1be56276e2b7dce1fdd1b5f49b:2
|
Funding @ 2013-08-08 19:02:21 UTC c662547b270f5ecd4cb00dd8f4b0acdf098d07a1aae379795a580cdf37fe1b9a:2
Spending @ 2013-08-23 22:42:47 UTC ae29fadc6905d2d01b89ef4dc76875c832492a9703014bd9912dc3165abfbbba:49
|
Funding @ 2013-07-17 17:47:07 UTC 8d7f20ceab4ad758007e99adcbcddd8fbbacc59f3a731ddde12fce6f0f755273:0
Spending @ 2013-08-25 18:29:58 UTC 7847760e4f4a5b5d5dd73fc5a9ac7617ba6f49048e90dbe8dbfcfa45953f6a5a:242
|
Funding @ 2013-07-12 15:38:03 UTC afdc497279aea167e6998990f69c619e03162484e16b9e88a4088e1f5ba55666:1
Spending @ 2013-07-12 18:15:42 UTC 6243e291dd7f90b2bdbb8964831753f55503b5d66091dcfa6beb7bdfbdcdf77e:22
|
Funding @ 2013-07-12 12:54:41 UTC f4aad6c499eb78ba421c8d3f39ddc5e24a6c8d93fb9c249d2cc35aafb66c3750:0
Spending @ 2013-07-12 15:17:29 UTC a67e18c88dfac654ef50b1feab1b256590b0ea60aff300eb38f8da3ae54d2af0:8
|
Funding @ 2013-07-10 05:57:16 UTC c99204ec408d0949565213d356b19163a303144b8c8c41595bd4ffa0ccbba735:0
Spending @ 2013-07-11 12:15:00 UTC 1f37dc2b1f7e16a6e3dd80813f58208ff55360000ddfab4f41b344dae2629b77:24
|
Funding @ 2013-06-26 10:25:45 UTC ff086be922637b583760b677dfdc355351b5c5f61ef6b222031c9d44ea5ee9af:1
Spending @ 2013-06-26 15:43:52 UTC 954f10ed2e2a625195c5639397d4e76493868de3f1b7d4dfeea4252e8658dfda:2
|
